Ads

 

Ads

 

Ads

 

World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as of August 2026.

Metatag Title
World Top Biopharmaceutical Companies 2026
Metatag Abstract
World Largest Biopharmaceutical Companies by Market Cap in 2026, World Top Biopharmaceutical Companies by Market Cap in 2026.
  1. Ligand Pharmaceuticals

    World Rank (Aug-2026)
    3,242
    Market Cap (Aug-2026)
    5.873 Billion USD
    World Rank (Jan-05-2024)
    7,621
    Market Cap (Jan-05-2024)
    1.227 Billion USD
    World Rank (Jul-30-2023)
    7,940
    Market Cap (Jul-30-2023)
    1.175 Billion USD
    World Rank (Dec-25-2022)
    5,769
    Market Cap (Dec-25-2022)
    1.822 Billion USD
    World Rank (Jan-07-2022)
    5,576
    Market Cap (Jan-07-2022)
    2.42 Billion USD
    Annual Revenue in USD
    268 Million USD
    Annual Operating Income in USD
    41 Million USD
    Annual Net Income in USD
    124 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Ligand Pharmaceuticals is a Biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. It is providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. The headquarters is in USA.
  2. Syneos Health

    World Rank (Aug-2026)
    3,312
    World Rank (Jan-05-2024)
    3,312
    World Rank (Jul-30-2023)
    3,312
    Market Cap (Jul-30-2023)
    4.404 Billion USD
    World Rank (Dec-25-2022)
    3,511
    Market Cap (Dec-25-2022)
    3.681 Billion USD
    World Rank (Jan-07-2022)
    1,964
    Market Cap (Jan-07-2022)
    9.52 Billion USD
    Annual Revenue in USD
    5,393 Million USD
    Annual Operating Income in USD
    403 Million USD
    Annual Net Income in USD
    266 Million USD
    Annual Results for Period Ending
    For year ending December-2022
    Headquarters Country
    Company Profile

    Syneos Health is a Biopharmaceutical Solutions company. It having approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. The headquarters is in USA.

    Syneos Health was acquired by a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital, and Veritas Capital for $43.00 per share in cash in a transaction valued at approximately $7.1 billion, including outstanding debt. Definitive agreement related to the acquisition was made in May-2023.

  3. SK Biopharmaceuticals

    World Rank (Aug-2026)
    3,683
    Market Cap (Aug-2026)
    4.915 Billion USD
    World Rank (Jan-05-2024)
    2,458
    Market Cap (Jan-05-2024)
    6.236 Billion USD
    World Rank (Jul-30-2023)
    2,963
    Market Cap (Jul-30-2023)
    5.022 Billion USD
    World Rank (Dec-25-2022)
    3,068
    Market Cap (Dec-25-2022)
    4.349 Billion USD
    World Rank (Jan-07-2022)
    2,773
    Market Cap (Jan-07-2022)
    6.17 Billion USD
    Annual Revenue in USD
    189 Million USD
    Annual Operating Income in USD
    -101 Million USD
    Annual Net Income in USD
    -107 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile

    SK Biopharmaceuticals is a Biopharmaceutical company that develops new drugs in support of innovations in the medical field. The headquarters is in South Korea.

  4. Shanghai Junshi Biosciences

    World Rank (Aug-2026)
    3,690
    Market Cap (Aug-2026)
    4.896 Billion USD
    World Rank (Jan-05-2024)
    3,008
    Market Cap (Jan-05-2024)
    4.826 Billion USD
    World Rank (Jul-30-2023)
    2,973
    Market Cap (Jul-30-2023)
    5.002 Billion USD
    World Rank (Dec-25-2022)
    2,075
    Market Cap (Dec-25-2022)
    6.872 Billion USD
    World Rank (Jan-07-2022)
    2,456
    Market Cap (Jan-07-2022)
    7.22 Billion USD
    Annual Revenue in USD
    204 Million USD
    Annual Operating Income in USD
    -381 Million USD
    Annual Net Income in USD
    -334 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Shanghai Junshi Biosciences is an Innovation Driven Biopharmaceutical company. The company annual revenue is 111 million USD and 1,357 employee as on 2020. The headquarters is in China.
  5. GW Pharmaceuticals

    World Rank (Aug-2026)
    3,962
    World Rank (Jan-05-2024)
    3,962
    World Rank (Jul-30-2023)
    3,962
    World Rank (Dec-25-2022)
    3,962
    World Rank (Jan-07-2022)
    3,962
    Annual Revenue in USD
    527 Million USD
    Annual Net Income in USD
    -58 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile

    GW Pharmaceuticals is a position in the development of plant derived cannabinoid therapeutics through it proven drug discovery and development processes intellectual property portfolio and regulatory and manufacturing expertise. The headquarters is in UK.

  6. Legend Biotech Corp

    World Rank (Aug-2026)
    4,232
    Market Cap (Aug-2026)
    3.931 Billion USD
    World Rank (Jan-05-2024)
    1,758
    Market Cap (Jan-05-2024)
    9.316 Billion USD
    World Rank (Jul-30-2023)
    1,285
    Market Cap (Jul-30-2023)
    13.797 Billion USD
    World Rank (Dec-25-2022)
    1,780
    Market Cap (Dec-25-2022)
    8.340 Billion USD
    World Rank (Jan-07-2022)
    2,553
    Market Cap (Jan-07-2022)
    6.83 Billion USD
    Annual Net Income in USD
    -297 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    Legend Biotech is a Multinational Biopharmaceutical company. It is focused on continuous innovation in the field of cell therapy and also future focused on emerging technologies that can help address some of the most chronic and life threatening diseases. The company annual revenue is 117 million USD and 1,390 employees as on 2022. The headquarters is in USA.

  7. Viking Therapeutics

    World Rank (Aug-2026)
    4,274
    Market Cap (Aug-2026)
    3.872 Billion USD
    World Rank (Jan-05-2024)
    5,954
    Market Cap (Jan-05-2024)
    1.859 Billion USD
    World Rank (Jul-30-2023)
    7,050
    Market Cap (Jul-30-2023)
    1.442 Billion USD
    World Rank (Dec-25-2022)
    10,811
    Market Cap (Dec-25-2022)
    0.648 Billion USD
    World Rank (Jan-07-2022)
    16,059
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -393 Million USD
    Annual Net Income in USD
    -360 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Viking Therapeutics is a Clinical Stage Biopharmaceutical company. It is focused on the development of novel, orally available, first in class or best in class therapies for the treatment of metabolic and endocrine disorders. The company annual revenue is 7.3 million USD and 15 employees as 2019. The headquarters is in USA.
  8. Walvax Biotechnology

    World Rank (Aug-2026)
    4,299
    Market Cap (Aug-2026)
    3.831 Billion USD
    World Rank (Jan-05-2024)
    2,859
    Market Cap (Jan-05-2024)
    5.127 Billion USD
    World Rank (Jul-30-2023)
    2,449
    Market Cap (Jul-30-2023)
    6.251 Billion USD
    World Rank (Dec-25-2022)
    1,641
    Market Cap (Dec-25-2022)
    9.186 Billion USD
    World Rank (Jan-07-2022)
    1,379
    Market Cap (Jan-07-2022)
    14.62 Billion USD
    Annual Revenue in USD
    713 Million USD
    Annual Operating Income in USD
    187 Million USD
    Annual Net Income in USD
    102 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Biotechnology company with headquarters is in China.
  9. Arcus Biosciences

    World Rank (Aug-2026)
    4,362
    Market Cap (Aug-2026)
    3.754 Billion USD
    World Rank (Jan-05-2024)
    6,836
    Market Cap (Jan-05-2024)
    1.477 Billion USD
    World Rank (Jul-30-2023)
    7,002
    Market Cap (Jul-30-2023)
    1.455 Billion USD
    World Rank (Dec-25-2022)
    6,609
    Market Cap (Dec-25-2022)
    1.478 Billion USD
    World Rank (Jan-07-2022)
    5,322
    Market Cap (Jan-07-2022)
    2.63 Billion USD
    Annual Revenue in USD
    33 Million USD
    Annual Operating Income in USD
    -386 Million USD
    Annual Net Income in USD
    -353 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Arcus is a Biopharmaceutical company aiming to bring together scientists, physicians and advisors to focus on developing best in class cancer therapies. The company annual revenue is 77.8 million USD and 108 employees as on 2019. The headquarters is in USA.
  10. Hualan Biological Engineering

    World Rank (Aug-2026)
    4,518
    Market Cap (Aug-2026)
    3.577 Billion USD
    World Rank (Jan-05-2024)
    2,715
    Market Cap (Jan-05-2024)
    5.501 Billion USD
    World Rank (Jul-30-2023)
    2,567
    Market Cap (Jul-30-2023)
    5.908 Billion USD
    World Rank (Dec-25-2022)
    2,562
    Market Cap (Dec-25-2022)
    5.408 Billion USD
    World Rank (Jan-07-2022)
    2,153
    Market Cap (Jan-07-2022)
    8.42 Billion USD
    Annual Revenue in USD
    633 Million USD
    Annual Operating Income in USD
    209 Million USD
    Annual Net Income in USD
    151 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Biopharmaceutical company with headquarters is in China.

Share

Ads